Population health & analytics · Post-acute care coordination
Olio
Olio is a care-coordination platform that connects hospitals, payers, and post-acute providers around transitions of care and shared workflows. It is not an FQHC quality-reporting suite or OR capacity tool.
Strong fit
- Health systems and payers that need shared care coordination across hospitals and post-acute partners
- Teams that will track readmissions, length of stay, and patients lost to outside providers after go-live
- Buyers comparing post-acute collaboration tools rather than large risk-scoring suites
Weak fit
- Community health centers that only need UDS quality dashboards
- Buyers looking to plan operating room capacity
- Organizations with no post-acute network to coordinate
Bottom line
Olio is worth considering for health systems and payers whose main problem is coordinating care with post-acute partners. It suits programs whose discharge partners will work inside a shared workflow. Buyers wanting post-acute market intelligence may prefer Trella, and community health center analytics teams should look at Azara or Relevant.
Score breakdown
Weights: Outcomes 35% · Product 30% · Implementation 20% · Pricing clarity 15%.
Olio makes care coordination software that connects hospitals, payers, and post-acute providers around patient handoffs and shared work. It is not another risk dashboard.
Results look strongest when discharge partners work inside the shared system and readmissions improve.
It covers some of the same post-acute ground as Trella, but it is more about shared work and collaboration. It is different from Azara's analytics for community health centers.
Setup is a project across your partner network, and pricing is custom.
Among the population health tools we review, Olio scores near Elligint and above Relevant for post-acute coordination.
Trella suits post-acute market research. Azara or Relevant suit community health center analytics teams rather than programs coordinating hospital-to-nursing-facility care.
Competitor landscape
| Vendor | Overall | Ease of implementation |
|---|---|---|
| Azara Healthcare | 7.6 | 7.2 |
| Cozeva | 7.5 | 7.2 |
| Persivia | 7.4 | 7.1 |
| Syra Health | 7.4 | 7.1 |
| Certilytics | 7.3 | 7.0 |
| Trella Health | 7.3 | 7.0 |
| IMAT Solutions | 7.0 | 6.7 |
| Elligint Health | 6.9 | 6.6 |
| Olio | 6.9 | 6.7 |
| Lightbeam Health Solutions | 6.8 | 6.5 |
| Relevant Healthcare | 6.8 | 6.6 |
| Hexplora | 6.7 | 6.5 |
Pricing
| Item | Detail |
|---|---|
| Model | Custom software for care coordination across hospital and post-acute networks. |
| What usually drives cost | Facilities in the network, users, modules, and setup services. |
| What to ask before you buy | Yearly cost for your hospitals and post-acute partners, and how partner seats are licensed. |
| Published pricing | Olio does not publish prices. Expect a mid-sized quote for care coordination. |
Prerequisites for purchase
| Need | Why it matters |
|---|---|
| What you need to get Olio to function | |
| A named population health or quality owner who can direct care gap work | Dashboards with no owner get ignored. |
| A clear definition of which patients count, agreed with finance | A vague patient count wipes out claimed savings. |
| A list of EHR, claims, and admission and discharge alert feeds | Missing data brings back blind spots. |
| Care managers or partners with time to act on lists | Lists nobody works are not results. |
| Contract measures chosen before kickoff | Changing the target midway wastes the work. |
| What will maximize your value | |
| Track closed gaps, readmissions, or use of services every week for 90 days | Counting logins does not show results. |
| Start with one patient group or partner network | A small real win is worth more than a broad launch with nothing behind it. |
| Drop duplicate spreadsheet lists after a month of running both | Entering everything twice doubles the cost. |
| Review high-risk or transferring patients nobody has reached in a regular huddle | Queues nobody watches hide failure. |
| Send a quarterly results summary to clinical leaders | Hidden backlogs surprise the board. |
| Deal-breakers | |
| You have no value-based, quality, or post-acute program to act on. | |
| Nobody will own follow-up work. | |
| You refuse any EHR or claims data sharing. | |
| You expect a population health tool to replace your EHR. | |
| Leaders will not measure results. | |
Value creation time frame
| # | Stage | Typical range |
|---|---|---|
| 1 | Plan and data | 4-8 weeks to define patients, data feeds, and success measures. |
| 2 | Connect | 2-4 months to connect claims, EHR, and admission alerts, then check the data. |
| 3 | Pilot | 1-2 months with one contract, site, or group of partners. |
| 4 | Expand | Ongoing: more patients and fine-tuning of care work. |
Leadership
Methodology
| Weight | Factor | What it measures |
|---|---|---|
| 35% | Customer outcomes | Whether buyers get measurable operational or clinical-workflow results after go-live |
| 30% | Product | Capability depth, reliability, and fit for the job the category buys |
| 20% | Implementation | How hard it is to stand up, integrate, train, and stabilize |
| 15% | Pricing clarity | Whether a buyer can model total cost without a mystery quote |
| Label | Meaning |
|---|---|
| Highly recommend | Strong outcomes and product with manageable caveats |
| Recommend | Solid fit for the right buyer; know the tradeoffs |
| Conditional | Only with a specific use case or heavy caveats |
| Not recommended | Avoid for most buyers in this category |
Read our full methodology for how we weight scores and assign recommend labels.